News & Trends

• 072024-04

  JK07 for the treatment of chronic heart failure in adults was approved for Phase II clinical trial in China Abstract: A Phase II clinical trial in adults with chronic heart failure (RENEU-HF) was initiated

• 142023-12

  Salubris' innovative drugs Allisartan and Enarodustat® were enrolled into 2023 National Reimbursement Drug List(NRDL)

• 102023-10

  New overseas clinical progress of JK07 for the treatment of chronic heart failure (HFrEF)

• 082023-10

  SAL0120 tablets for treatment of IgA nephropathy approved for clinical trial

• 102023-08

  Vena cava filter system (SaExten®) approved by NMPA

• 092023-06

  Enarodustat（恩那罗®） Approved by NMPA for Treatment of Renal Anemia (Abstract) NMPA approved Enarodustat（恩那罗®）